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ABSTRACT
Nasogastric (NG) tubes are commonly used for enteral feeding. Complications of feeding tube misplacement 
include malnutrition, pulmonary aspiration, and even death. We built a Bayesian network (BN) to analyse the 
risks associated with available bedside tests to verify tube position.  Evidence on test validity (sensitivity and 
specificity) was retrieved from a systematic review. Likelihood ratios were used to select the best tests for 
detecting tubes misplaced in the lung or oesophagus. Five bedside tests were analysed including magnetic 
guidance, aspirate pH, auscultation, aspirate appearance, and capnography/colourimetry. Among these, 
auscultation and appearance are non-diagnostic towards lung or oesophagus placements. Capnography/
colourimetry can confirm but cannot rule out lung placement. Magnetic guidance can rule out both lung 
and oesophageal placement. However, as a relatively new technology, further validation studies are needed. 
The pH test with a cut-off at 5.5 or lower can rule out lung intubation. Lowering the cut-off to 4 not only 
minimises oesophageal intubation but also provides extra safety as the sensitivity of pH measurement 
is reduced by feeding, antacid medication, or the use of less accurate pH paper. BN is an effective tool 
for representing and analysing multi-layered uncertainties in test validity and reliability for the verification 
of NG tube position. Aspirate pH with a cut-off of 4 is the safest bedside method to minimise lung and 
oesophageal misplacement.
Keywords: Decision analysis, Bayesian networks, nasogastric tube, patient safety.
INTRODUCTION
At least one million nasogastric (NG) feeding tubes 
are purchased by the National Health Service in 
England each year. Complications of feeding tube 
misplacement include malnutrition, pulmonary 
aspiration, and even death. For blind insertion, 
the rate of respiratory placement is typically 1-3%. 
Inadvertent tube placement in the oesophagus was 
observed in 19 out of 100 blind NG tube insertions.1 
Reported rates of tube misplacement on insertion 
and tube migration after correct initial placement 
vary between 1.3% and 50% in adults.2
There is a distinct lack of consensus as to the 
optimum method of checking the feeding tube 
position. In response to several deaths directly 
related to NG tube misplacement, the National 
Patient Safety Agency (NPSA) in England issued 
safety alerts in February 2005 to describe correct 
procedures for checking the position of feeding 
tubes.3,4 However, additional cases of death due 
to NG tube misplacement have been reported 
since the circulation of these alerts. Possible 
reasons include the use of inappropriate 
checking procedures or the misinterpretation of 
radiographs by clinicians. Also documented are 
the life-threatening complications from enteral 
formulations or medications entering the lung 
through a misplaced NG tube, i.e. ‘aspiration-by-
proxy’, that did not result in patient harm.5 The 
most recent safety guideline forbids the use 
of auscultation (‘the whoosh test’), while 
recommending testing of the tube aspirate pH 
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(cut-off 5.5) and the use of chest radiographs 
whenever necessary.6 
The task to correctly position a blindly inserted NG 
tube is challenging because none of the bedside 
procedures can provide definitive verification of 
tube position. Even the current gold standard of 
a chest radiograph is prone to misinterpretation. 
We were commissioned by NPSA to review the 
safety of using bedside methods to verify NG tube 
position with an emphasis on confirming initial tube 
placements prior to feeding. 
METHODS 
A Bayesian network (BN) was constructed to 
analyse risks in safe feeding. BNs are graphical 
tools for reasoning with uncertainties.7-9 They can 
be viewed as a special knowledge network that 
captures one’s beliefs in a risky decision. Each node 
(circle) represents an uncertain event; each arrow 
(or edge) represents dependence between two 
events, and the lack of arrow indicates conditional 
independence. The structure of a BN reflects how 
we think different events relate to each other. The 
numerical part of a BN in the form of conditional 
probabilities reflects the strength of such 
dependence. In the case of NG tube positioning, 
the tube site is the shared parent node of different 
bedside tests. Arrows pointing out from tube site 
and into the bedside tests indicate our belief that 
the outcome of these tests depend, among other 
things, on the location of the feeding tube which 
could be lung, intestine, stomach, or oesophagus. 
No arrows, however, link different tests together 
because we believe that the outcome of one test 
(its findings) does not depend on those of another 
test (conditional independence). For aspirate pH, 
feeding and medication history of a patient were 
modelled as additional parents of the pH test; pH 
paper was modelled as a child of pH meter (which 
is a child of tube site). This allows us to examine test 
results from various combinations of feeding and 
medication conditions, as well as to test using a less 
reliable measurement of pH.
We capture the risk of tube misplacement during 
initial insertion (i.e. before checking) in the prior 
distribution of the tube sites. Test validity (i.e. 
sensitivity and specificity) was incorporated as 
conditional probability of a finding in each tube 
site. Once a finding has been entered into the BN, 
the prior distribution will be updated according 
to the Bayes’ rule. The result is the posterior 
distribution of the tube sites that reflects one’s 
revised belief about the location of the NG 
tube in light of the finding. We built the BN in 
software Netica®.
Information on test validity was retrieved from a 
systematic review in which chest X-rays served as 
the gold-standard. Multiple sources of information 
on the same test were combined by a simple 
weighted average, based on sample size. Missing 
information was dealt with by assuming a flat 
distribution where all the findings were assumed 
to be equally likely. For aspirate pH, raw data 
were kindly provided by the author (Prof Norma 
Metheny).10-16 This enabled a detailed study of 
the influence of antacid medication and feeding 
status of a patient, as well as measurement 
methods such as Baxter paper versus pH meter. 
We generally assume that the tube had 20%, 50%, 
20%, and 10% probabilities of being inserted into 
the lung, stomach, oesophagus, and small bowel, 
respectively.1,2 We also tested scenarios of low 
initial risks (prior probabilities of lung/stomach/
oesophagus/small bowel =10%/80%/10%/0%) and 
high initial risks (prior =30%/35%/25%/10%) where 
tube misplacements were respectively 30% and 
65% of the time, compared to 50% of the time, as 
widely assumed. The likelihood of safe feeding 
varies with tube site. The consequences of feeding 
into a misplaced tube in the lung are the most 
severe, followed by oesophagus, and small bowel. 
We used likelihood ratios (LRs) to prioritise safety 
needs. LR1, LR2, and LR3 measured the capacity 
of a test to detect tubes in the lung, oesophagus, 
and small bowel in contrast to the stomach (the 
correct tube site).(*)
LR1= p(finding|not lung) /p(finding|lung) 
LR2=p(finding|stomach)/p(finding|oesophagus)
LR3=p(finding|stomach)/p(finding|small bowel)
Two types of findings are worth noting. Infinite 
LR1, LR2, and LR3 indicate that lung, oesophagus, 
and small bowel misplacements are ruled out, in 
which case feeding can safely start. An example 
is the finding of a stomach tube using correctly 
interpreted chest X-rays, the current gold-standard. 
Secondly, zero LRs would confirm the lack of 
safety as the tube is in the lung (LR1) or outside the 
stomach (LR2 and LR3). This happens when a lung 
tube is found by correctly interpreted chest X-rays. 
Note that under the assumption of conditional 
independence, the utility of several tests, when used 
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together to verify tube site, was simply the product 
of their respective LRs.
RESULTS  
Aspirate pH,10-13,16 appearance,11 auscultation,10,17 
capnography/colourimetry,11 and magnetic 
guidance18 emerged from our literature review as 
existing or potential bedside tests for locating 
blindly inserted NG tubes. The BN is shown in 
Figure 1. Contained within each bedside test are its 
findings; next to each finding is the joint (average) 
probability of observing the finding given the 
test validity (Table 1(**)) and the prior probabilities 
that the tube is inserted into the lung, stomach, 
oesophagus, and small bowel, respectively (i.e. 
20%, 50%, 20%, and 10%; Figure 1). Note that we 
included the discredited auscultation test in our 
analysis, for two reasons: firstly to provide a check 
on the validity of model predictions and secondly, 
to analyse its potential when used in combination 
with other tests. For the aspirate pH, we chose 4.0, 
5.0, 5.5, and 6.0 as the cut-offs (findings). Table 1 
presents the combined (averaged) sensitivity of 
each finding of each test. The pH from oesophageal 
intubation was extrapolated from studies on reflux 
patients, which together demonstrate that the 
median percentage time with oesophageal pH 
measured <4.0, is between 0.5-3.1% of recorded 
24-hour periods in healthy individuals;19-24 sensitivity 
of the pH test above 4 was assumed to be evenly 
distributed. A lack of high-quality evidence for 
auscultation test also led us to assume that the 
loudest sound was equally likely to be heard 
in epigastrium, left upper quadrant (LUQ), and 
right upper quadrant (33% in each case) through 
lung tubes.  
Figure 1: The Bayesian Network model for the safe verification of nasogastric tubes.
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Table 1: Sensitivity of the bedside tests in positioning blindly inserted NG tubes.
Test Findings Lung Stomach Oesophagus Small Bowel
pH Meter ≤4 0.00 54.60% 5.00% 6.26%
≤5 0.00 67.80% 30.00% 10.13%
≤5.5 0.00 75.23% 55.00% 11.80%
<6 0.36% 84.51% 80.00% 14.38%
≥6 99.60% 15.50% 20.00% 85.60%
Auscultation Epigastrium 33.30% 29.20% 62.00% 73.60%
LUQ 33.30% 41.60% 19.00% 22.40%
RUQ 33.30% 29.20% 19.00% 4.00%
Appearance Lung 46.10% 21.20% 33.30% 20.00%
Stomach 26.90% 57.60% 33.30% 20.00%
Small bowel 26.90% 21.20% 33.30% 60.00%
Capnography CO2 present 89.30% 0.40% 0.40% 0.40%
CO2 absent 10.70% 99.60% 99.60% 99.60%
Magnetic Below diaphragm 0.00 75.00% 0.00 75.00%
Guidance Above diaphragm 100.00% 25.00% 100.00% 25.00%
NG: nasogastric; LUQ/RUQ: left/right upper quadrant.
Table 2: The effectiveness of the bedside tests to rule out lung and oesophagus (infinite LRs).
Test Findings LR1 LR2 LR3
pH ≤4 Infinite 10.92 8.72
≤5 Infinite 2.26 6.69
≤5.5 Infinite 1.37 6.38
<6 207.22 1.06 5.88
≥6 0.26 1.29 0.18
Auscultation epigastrium 1.29 0.47 0.40
LUQ 1.01 2.19 1.86
RUQ 0.71 1.54 7.30
Appearance lung 0.52 0.64 1.06
stomach 1.74 1.73 2.88
small bowel 1.08 0.64 0.35
Capnography CO2 present 0.004 1.00 1.00
CO2 absent 9.31 1.00 1.00 
Magnetic guidance below diaphragm Infinite Infinite 1.00
above diaphragm 0.44 0.25 1.00
LRs: likelihood ratios; LR1: p(finding|not lung)/p(finding|lung); LR2: p(finding|stomach)/
p(finding|oesophagus); LR3: p(finding|stomach)/p(finding|small bowel); LUQ/RUQ: left/right 
upper quadrant.
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Table 2(**) presents the LRs based on test validity 
(Table 1) and the prior. A quick scan of Table 2 
shows that the best tests to detect lung intubation, 
as indicated by an infinite LR1, are pH (5.5 or lower) 
or magnetic guidance (below diaphragm), and the 
best tests to detect oesophageal intubation, as 
indicated by an infinite LR2, are magnetic guidance 
(below diaphragm), followed by aspirate pH 
with a cut-off at 4. The latter can reduce the 
chance of oesophagus placement relative to 
stomach placement by nearly 10-fold (LR2=10.92). 
In contrast, the chance of oesophagus placement 
would barely change when a pH of 5.5 or less is 
observed (LR2=1.37).
Using the BN model in Netica, a pH of 5.5 or less 
would predict the probabilities of lung, stomach, 
oesophagus, and small bowel placements are 0%, 
75.5%, 22.1%, and 2.37% respectively, in contrast 
to the initial 20%, 50%, 20%, and 10%.  A pH of 
4.0 or less would predict the probabilities of lung, 
stomach, oesophagus, and small bowel placements 
are 0%, 94.4%, 3.46%, and 2.16%, respectively. That 
is, a pH at 4 or less reduces the risk of oesophageal 
intubation from 20% to 3.46%, i.e. from fairly 
uncertain to ‘beyond reasonable doubt’.
Auscultation and appearance are not useful on 
their own as their LRs clustered around 1. The only 
finding useful in terms of lung and oesophagus 
intubations is the auscultation test which found 
the loudest sound heard in the LUQ (LR2=2.19). 
This would halve the chance of oesophageal 
placement (from 20% to 11.3%) relative to stomach 
placement (from 50-62.1%). Using capnography 
or colourimetry, detecting CO2 would increase the 
chance of lung tubes from 20-98% (LR1=0.004). 
However, the absence of CO2 cannot be taken as 
definitive evidence that the tube is outside the 
lung (LR1 =9.31), and the revised belief of lung 
placement is 2.62%.
Feeding, Antacid Medication, and Measurement 
Technique Effects on pH Test 
Recent feeding, administration of antacid therapy, 
or using pH paper instead of meter to measure pH, 
all reduce sensitivity of the pH test. Given a pH of 
5.5 or less, receiving antacids would increase the 
chance of oesophagus placement from 22.1-23.6%, 
though feeding had little impact. Given the finding 
of a pH of 4.0 or less, receiving antacids would 
increase the chance of oesophagus placement from 
3.46-4.05% and further to 4.20% if the patient has 
recently been fed. If Baxter paper is used instead 
of pH, the reading of 4 or less would predict the 
probabilities of stomach, oesophagus, and small 
bowel placements to be 89.2%, 8.49%, and 2.30%, 
whereas a reading of 5.5 or less would predict the 
probabilities of lung, stomach, oesophagus, and 
small bowel placements to be 0.024%, 78%, 19.6%, 
and 2.41%.
Impact of Low or High Initial Risks on pH 
If a pH of 4 or less was observed, the predicted 
probabilities of lung, stomach, oesophagus, and 
small bowel placements were respectively 0%, 
98.9%, 1.13%; 0% under low level of initial risks; and 
0%, 91.1%, 5.96%, and 2.98% under high level of 
initial risks. If a pH of 5.5 or less was observed, the 
chances of lung, stomach, oesophagus, and small 
bowel placements were 0%, 91.6%, 8.37%, and 
0% likely under low level of initial risks and 0%, 
63.8%, 33.3%, and 2.86% likely under high level of 
initial risks.
Assume a worst case scenario where the initial 
insertions have a high risk of misplacements and 
the verification is done by Baxter paper instead of 
pH meter. A finding of a pH of 5.5 or less would 
predict lung, oesophagus, and small bowel 
misplacements to be 0%, 54.6%, and 2.03% 
respectively, whereas a pH of 4 or less would 
predict the probabilities of lung, oesophagus, 
and small bowel misplacements to be 0%, 8.49%, 
and 2.30%, respectively. That is, if a patient is 
fed after a pH of 5.5 or less is observed in the 
worst case scenario, then half of the time the 
feeding would be in the oesophagus instead of 
the stomach. 
DISCUSSION  
Five bedside tests were investigated, i.e. magnetic 
guidance, aspirate pH (with cut-offs 4, 5, 5.5, 
and 6), auscultation, aspirate appearance, and 
capnography/colourimetry. Consistent with the 
existing literature and the recommendation of 
NPSA, neither auscultation nor aspirate appearance 
can be recommended for use on their own to detect 
tube misplacements in the lung or oesophagus. It 
is worth noting that if capnography/colourimetry 
is used, the absence of CO2 cannot be taken as 
evidence for safe feeding (outside the lung) because 
such findings are observed in 10.7% of the lung 
placements (Table 1). The safest tests are magnetic 
guidance and pH of tube aspirate. Magnetic 
guidance can rule out lung or oesophageal 
placement – the two most hazardous potential tube 
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sites, whereas a pH test with cut-offs at 5.5 or lower 
can rule out lung misplacements. Further lowering 
the cut-off to 4 or less would minimise oesophagus 
misplacements. Magnetic guidance is a relatively 
new technology and has a relatively small, though 
growing, evidence base (n=243).
Magnetic guidance has been studied in adults and 
children, particularly in the context of post-pyloric 
feeding with retrospective studies.25-27 More recent 
prospective studies indicate encouraging accuracy 
of the technique28 but there are additional costs 
of technical equipment and devices required for 
every tube placement29 and the process does not 
eliminate the risk of adverse soft tissue injury.30 
Further validation studies are needed. 
The pH test of tube aspirates is widely used, well-
studied, and has an established evidence base 
(nearly 800 cases in our database). Current practice 
also recommends the use of aspirate pH, though 
with a cut-off of 5.5. Our analysis shows lowering 
the pH cut-off from 5.5 to 4.0 can enhance safety 
in oesophageal intubations. Furthermore, the use 
of Baxter paper, feeding, medication history of a 
patient, and potential variations in the risks in the 
initial insertions of the tube, means a lower pH 
would provide an extra layer of safety for reducing 
oesophageal feeding. Lowering the pH threshold 
would result in more patients with tubes correctly 
placed in the stomach to be sent for X-rays 
(unnecessary X-rays). It is therefore a trade-off that 
needs careful assessment: minimising placement 
errors (mainly in the oesophagus) versus minimising 
unnecessary X-rays. Consider three strategies in 
Table 3, i.e. X-ray all patients, X-ray only patients 
with pH higher than 5.5, or X-ray only patients with 
pH higher than 4. Under the assumption of 50% 
initial insertion errors, adopting a pH with a cut-off 
of 4 would reduce placement errors from 9.38% to 
0.62% whilst increasing unnecessary X-rays from 
24.15-34.05% (Table 3). 
Table 3: Outcomes of clinical guidelines. 
Placement Errors Unnecessary X-ray
pH ≤5.5 feed; X-ray everyone with pH>5.5 9.38% 24.15%
pH ≤4 feed; X-ray everyone with pH>4 0.62% 34.05%
X-ray everyone 0 75%
One criticism of our recommendation of lowering 
the pH cut-off is that X-ray facilities are not widely 
available and therefore lowering the pH may lead 
to feeding delays and potential harm from lack of 
nutrition.6 Another criticism surrounds the liability 
of chest radiographs to be misinterpreted.  Reducing 
the pH cut-off used for tube aspirate pH testing 
may expose patients to a risk of inadvertent feeding 
if the consequent increase in radiographs to check 
tube position is associated with an accompanying 
increase in X-ray misinterpretation. This is debatable 
as misinterpretation of radiographs affects a cohort 
of patients with a tube aspirate pH between 4.0 
and 5.5. Using the current guideline with a higher 
pH cut-off (5.5), all of these patients will be fed 
through the tube regardless of the actual tube site. 
Given a constant rate of tube misplacement, it is 
not possible to increase the number of inadvertent 
feeding errors using a lower pH cut-off, regardless 
of the risk of X-ray misinterpretation.  
In terms of using multiple tests instead of a single 
test, consider safety needs to rule out lung and 
oesophagus placements. Magnetic guidance can 
achieve both ends on its own; the best test to be 
used with aspirate pH is one that is sensitive to 
oesophageal misplacement. Auscultation has 
the potential to halve the chance of oesophagus 
placement, but the method is subject to 
interpretation errors and is therefore unreliable. 
CONCLUSIONS   
The key to maximising the safety of NG tube 
feeding is to rule out feeding into the lung and to 
minimise feeding into the oesophagus. A critical 
step to prevent inadvertent administration of 
enteral feed into the bronchopulmonary tract 
is reliable confirmation of tube position prior to 
commencing feeds. There is also the potential 
for soft tissue trauma caused during incorrect 
tube insertion. A recent study reports 35 (18.7%) 
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